FDA To Study TV Drug Advertising

The FDA has announced a new study on whether visuals in drug advertising distract consumers from understanding the risks.   The announcement, on the FDA’s website, proposes a one-time study about the perceived riskiness of a drug based on its advertising.  As Business Week reports (via AP), among industrialized countries, only the United States and New Zealand allow television drug advertising. 

– SBS